HDAC5 and breast carcinoma: Proteomic analysis with an antibody array identified proteins that were differentially expressed between breast cancer patients with and those without recurrence (34); moreover, HDAC5 was detected at a significantly higher level in the blood in patients with recurrent breast cancer than in those with recurrent triple-negative breast cancer.